Join
Live feed
·
INSIDERFilingvia Quantisnow
Calidi Biotherapeutics Inc. logo

CEO and Chairman of the Board Camaisa Allan was granted 70,155 shares (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
CLDI· Calidi Biotherapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLDI (Calidi Biotherapeutics Inc.) and more on Quantisnow.

CEO and Chairman of the Board Camaisa Allan was granted 70,155 shares (SEC Form 4) | Quantisnow